Literature DB >> 9651526

MDM2 expression during mouse embryogenesis and the requirement of p53.

T Léveillard1, P Gorry, K Niederreither, B Wasylyk.   

Abstract

We compared mouse embryonic expression of the MDM2 proto-oncogene, p21WAF1/CIP1 and their transcriptional regulator, p53. MDM2 expression is ubiquitous from 7.5 to 11.5 days post coitum (dpc) and more restricted from 12.5 dpc, with the highest levels in the testes and neural tube. From 14.5 to 18.5 dpc, the nasal respiratory epithelium expresses high levels of MDM2 RNA and protein and p21WAF1/CIP1 RNA, in both wild type and p53 null embryos. MDM2 expression during development is tissue-specific and, like p21WAF1/CIP1, is independent of p53. MDM2 may have a developmental role after 6.5 dpc, when MDM2 null mice die (Jones, S.N., Roe, A.E., Donehower, L.A., Bradley, A., 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208; Montes de Oca Luna, R., Wagner, D.S., Lozano, G., 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206). Copyright 1998 Elsevier Science Ireland Ltd. All rights reserved

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651526     DOI: 10.1016/s0925-4773(98)00074-4

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  15 in total

Review 1.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

2.  Mechanisms of p53 activation and physiological relevance in the developing kidney.

Authors:  Karam Aboudehen; Sylvia Hilliard; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-11

3.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 4.  Transcriptional control of terminal nephron differentiation.

Authors:  Samir S El-Dahr; Karam Aboudehen; Zubaida Saifudeen
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-20

5.  Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.

Authors:  Chuandong Fan; Xinjiang Wang
Journal:  Cell Cycle       Date:  2017-02-06       Impact factor: 4.534

Review 6.  The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.

Authors:  James J Manfredi
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

7.  The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress.

Authors:  S M Mendrysa; M E Perry
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  A role for p53 in terminal epithelial cell differentiation.

Authors:  Zubaida Saifudeen; Susana Dipp; Samir S El-Dahr
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

9.  Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

Authors:  Sarah Francoz; Pascal Froment; Sven Bogaerts; Sarah De Clercq; Marion Maetens; Gilles Doumont; Eric Bellefroid; Jean-Christophe Marine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  The proto-oncogene function of Mdm2 in bone.

Authors:  David J Olivos; Daniel S Perrien; Adam Hooker; Ying-Hua Cheng; Robyn K Fuchs; Jung Min Hong; Angela Bruzzaniti; Kristin Chun; Christine M Eischen; Melissa A Kacena; Lindsey D Mayo
Journal:  J Cell Biochem       Date:  2018-07-16       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.